Skip to content

Clinical trials

Phase 2 Thyroid Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Phase 2 Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20151
20162
20172
20192
20203
20211
20222
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed6
Recruiting6
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University7
Peking Union Medical College Hospital2
West China Hospital2
Bayer1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Chinese Academy of Medical Sciences1
Eli Lilly and Company1
Hutchison Medipharma Limited1
National Cancer Institute (NCI)1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms21
Neoplasms3
Carcinoma, Medullary2
Carcinoma, Non-Small-Cell Lung2
Thyroid Carcinoma, Anaplastic2
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma1
Colorectal Neoplasms1
Melanoma1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.